Hipgnosis Stock Sinks to Yearly Low Following Critical Analyses — But J.P. Morgan Believes the Company ‘Offers Compelling Value’ For Investors

After two less-than-positive assessments of Hipgnosis Songs Fund’s long-term outlook entered the media spotlight earlier this month, the price of the entity’s stock (LON: SONG) touched a 2022 low. But according to an analysis from J.P. Morgan, SONG still “offers compelling value.” Per the Financial Times’ critical accounts of Hipgnosis Songs Fund’s position…
Read More